PMV Pharmaceuticals, Inc. (PMVP) Tops Q1 EPS by 3c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q1 EPS of ($0.34), $0.03 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• LeonaBio (LONA) Reiterated at Market Outperform by Citizens on Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy